Evidence map›Paper›PMID 23112852›Full record

ArticlePloS one2012

SIV genome-wide pyrosequencing provides a comprehensive and unbiased view of variation within and outside CD8 T lymphocyte epitopes.

Austin L Hughes, Ericka A Becker, Michael Lauck, Julie A Karl, Andrew T Braasch, David H O'Connor, Shelby L O'Connor

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. A Pan-HIV Strategy for Complete Genome Sequencing.Journal of clinical microbiology · 2016
    Article
  3. Article
  4. Within-host nucleotide diversity of virus populations: insights from next-generation sequencing.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2015
    Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Austin L HughesDepartment of Biological Sciences, University of South Carolina, Columbia, South Carolina, United States of America.
Ericka A Becker
Michael Lauck
Julie A Karl
Andrew T Braasch
David H O'Connor
Shelby L O'Connor
University of Wisconsin–Madison · USUniversity of South Carolina · US

Funding

WNPRC Supplemental Request for Nonhuman Primate Enclosures to Equip HIV/AIDS-Related Research FacilitiesP51OD011106 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI Dorota A. Grejner-Brzezinska · 2012 to 2026
$150.7M
ZOLEDRONATE PREVENTS BONE LOSS IN OVARIECTOMIZED RHESUS MONKEYSP51RR000167 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 1985 to 2011
$106.7M
Adoptive transfer of immunity elicited by attenuated HIV vaccinesR01AI077376 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI O'CONNOR, DAVID H. · 2008 to 2015
$5.4M
EXTRAMURAL RES FACIL CONST: REPRODUCTIVE, GROWTH &DVMT, MENOPAUSEC06RR020141 · NCRR · UNIVERSITY OF WISCONSIN MADISON · PI CADWALLADER, MARTIN · 2004 to 2004
$3.6M
Defining the importance of CD8+ T Cell Breadth in SIV/HIV protective immunityR01AI084787 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI FRIEDRICH, THOMAS C., O'CONNOR, DAVID H. · 2009 to 2013
$3.2M
EXTRAMURAL REGIONAL FACILITIES CONSTRUCTIONC06RR015459 · NCRR · UNIVERSITY OF WISCONSIN MADISON · PI CADWALLADER, MARTIN · 2000 to 2000
$1.9M
POLYMORPHISM &EVOLUTION OF MHC GENESR01GM043940 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI HUGHES, AUSTIN L. · 1990 to 2010
$1.5M
Exploring in vitro and in vivo T cell immunity to SIV with MHC-identical macaquesR33AI082880 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI O'CONNOR, DAVID H. · 2011 to 2013
$1.3M
SIV-Specific CD8+ T-Cell in Mauritian Cynomolgus MacaquesR21AI068488 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI O'CONNOR, DAVID H. · 2006 to 2007
$507k
Exploring in vitro and in vivo T cell immunity to SIV with MHC-identical macaquesR21AI082880 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI O'CONNOR, DAVID H. · 2009 to 2010
$402k
NCRR NIH HHS C06 RR015459NCRR NIH HHS C06 RR020141NCRR NIH HHS P51 RR000167NCRR NIH HHS RR020141-01NCRR NIH HHS RR15459-01NIAID NIH HHS R01 AI077376NIAID NIH HHS R01 AI084787NIAID NIH HHS R21 AI068488NIAID NIH HHS R21 AI082880NIAID NIH HHS R33 AI082880NIAID NIH HHS R33 AI082880-03NIGMS NIH HHS R01 GM043940NIGMS NIH HHS R01 GM43940-22NIH HHS P51 OD011106
6 · The paper itself

Abstract

Deep sequencing technology is revolutionizing our understanding of HIV/SIV evolution. It is known that acute SIV sequence variation within CD8 T lymphocyte (CD8-TL) epitopes is similar among MHC-identical animals, but we do not know whether this persists into the chronic phase. We now determine whether chronic viral variation in MHC-identical animals infected with clonal SIV is similar throughout the entire coding sequence when using a sensitive deep sequencing approach. We pyrosequenced the entire coding sequence of the SIV genome isolated from a unique cohort of four SIVmac239-infected, MHC-identical Mauritian cynomolgus macaques (MCM) 48 weeks after infection; one MCM in the cohort became an elite controller. Among the three non-controllers, we found that genome-wide sequences were similar between animals and we detected increased sequence complexity within 64% of CD8-TL epitopes when compared to Sanger sequencing methods. When we compared sequences between the MHC-matched controller and the three non-controllers, we found the viral population in the controller was less diverse and accumulated different variants than the viral populations in the non-controllers. Importantly, we found that initial PCR amplification of viral cDNA did not significantly affect the sequences detected, suggesting that data obtained by pyrosequencing PCR-amplified viral cDNA accurately represents the diversity of sequences replicating within an animal. This demonstrates that chronic sequence diversity across the entire SIV coding sequence is similar among MHC-identical animals with comparable viral loads when infected with the same clonal virus stock. Additionally, our approach to genome-wide SIV sequencing accurately reflects the diversity of sequences present in the replicating viral population. In sum, our study suggests that genome-wide pyrosequencing of immunodeficiency viruses captures a thorough and unbiased picture of sequence diversity, and may be a useful approach to employ when evaluating which sequences to include as part of a vaccine immunogen.

Indexed as

Amino Acid SequenceAnimalsCD8-Positive T-LymphocytesDNA, ViralEpitopes, T-LymphocyteGenome, ViralHigh-Throughput Nucleotide SequencingMacaca fascicularisMajor Histocompatibility ComplexRNA, ViralSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusViral LoadDNA, ViralEpitopes, T-LymphocyteRNA, Viral

Identifiers

PMID23112852
PMCPMC3480401
OpenAlexW1967202188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.